Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Chronic Pancreatitis II: Collaborative Care
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
Acute Pancreatitis II: Clinical Manifestations and Management
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 19, 2026

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
Published on: February 3, 2023
Michele M Tana1, Gideon M Hirschfield2
1Division of Gastroenterology and Hepatology, Department of Medicine, University of California San Francisco.
No abstract available in PubMed .